Nasdaq Falls 3% on Chip Stock Sell-Off and Diminishing Iran Deal Hopes

The NDX experienced a sharp decline of 5.5%, falling to 28,708, with the RSI entering oversold territory at 29.7. The MACD remains below the signal line and in negative territory, indicating sustained bearish momentum. The price is trading below both the 20-day (29,421) and 50-day (30,070) moving averages. News headlines confirm that selling pressure is amplified by a wave of selling in chip stocks and geopolitical uncertainties (Iran deal). Despite short-term oversold conditions, the downward trend suggests a high risk of continued decline.

NVDA fell 5.5% in the last close, with its RSI approaching oversold territory at 36.5. The MACD line is below the signal line and in negative territory, indicating weak short-term momentum. The price is trading below the 20- and 50-day moving averages, a technical structure that suggests weakness. The headline confirms that the sell-off in chip stocks is broad-based and market sentiment is negative. The downtrend is likely to continue in the short term, though some buying on the dip may occur due to the oversold condition.

AMD shares fell 12.5% in the last 24 hours to $458.23. While the RSI at 34.9 approaches oversold territory, the MACD line remains below the signal line and in negative territory. Trading below the 20- and 50-day moving averages weakens the short-term technical outlook. The Nasdaq's 3% decline amid a sell-off in chip stocks indicates reduced risk appetite across the sector. Therefore, downward pressure on AMD is expected to persist over the next 1-3 days.

Intel shares are directly impacted by the broad sell-off on the Nasdaq and the negative sentiment in the chip sector. Technical indicators confirm the weakness: the price is trading below both the 20-day and 50-day moving averages, and the RSI at 42.7 is approaching the oversold territory. The MACD line is below the signal line and in negative territory, indicating short-term downward momentum. The 5% decline in the last 24 hours suggests continued selling pressure. A short-term recovery appears unlikely, but since the stock has not yet entered oversold territory, a sharp acceleration of the decline is not expected either.